164 related articles for article (PubMed ID: 35787705)
1. Glycemic Variability Assessment in Newly Treated Exocrine Pancreatic Insufficiency With Type 1 Diabetes.
Lewis DM; Shahid A
J Diabetes Sci Technol; 2024 Mar; 18(2):430-437. PubMed ID: 35787705
[TBL] [Abstract][Full Text] [Related]
2. Exocrine pancreatic insufficiency following esophagectomy.
Huddy JR; Macharg FM; Lawn AM; Preston SR
Dis Esophagus; 2013 Aug; 26(6):594-7. PubMed ID: 23199208
[TBL] [Abstract][Full Text] [Related]
3. Exocrine Pancreatic Insufficiency Dosing Guidelines for Pancreatic Enzyme Replacement Therapy Vary Widely Across Disease Types.
Lewis DM; Rieke JG; Almusaylim K; Kanchibhatla A; Blanchette JE; Lewis C
Dig Dis Sci; 2024 Feb; 69(2):615-633. PubMed ID: 38117426
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiome as a response marker for pancreatic enzyme replacement therapy in a porcine model of exocrine pancreas insufficiency.
Ritz S; Hahn D; Wami HT; Tegelkamp K; Dobrindt U; Schnekenburger J
Microb Cell Fact; 2020 Dec; 19(1):221. PubMed ID: 33272255
[TBL] [Abstract][Full Text] [Related]
5. Exocrine Pancreas Dysfunction in Type 1 Diabetes.
Foster TP; Bruggeman B; Campbell-Thompson M; Atkinson MA; Haller MJ; Schatz DA
Endocr Pract; 2020 Dec; 26(12):1505-1513. PubMed ID: 33471743
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic enzyme replacement therapy after gastric resection: An update.
Antonini F; Crippa S; Falconi M; Macarri G; Pezzilli R
Dig Liver Dis; 2018 Jan; 50(1):1-5. PubMed ID: 29170072
[TBL] [Abstract][Full Text] [Related]
7. Perioperative management of pancreatic exocrine insufficiency-evidence-based proposal for a paradigm shift in pancreatic surgery.
Stern L; Schuette M; Goetz MR; Nitschke C; Bardenhagen J; Scognamiglio P; Stüben BO; Calavrezos L; Amin T; Heumann A; Lohse AW; de Heer G; Izbicki JR; Uzunoglu FG
HPB (Oxford); 2024 Jan; 26(1):117-124. PubMed ID: 37770362
[TBL] [Abstract][Full Text] [Related]
8. Frequency of Appropriate Use of Pancreatic Enzyme Replacement Therapy and Symptomatic Response in Pancreatic Cancer Patients.
Barkin JA; Westermann A; Hoos W; Moravek C; Matrisian L; Wang H; Shemanski L; Barkin JS; Rahib L
Pancreas; 2019 Jul; 48(6):780-786. PubMed ID: 31210656
[TBL] [Abstract][Full Text] [Related]
9. Less common etiologies of exocrine pancreatic insufficiency.
Singh VK; Haupt ME; Geller DE; Hall JA; Quintana Diez PM
World J Gastroenterol; 2017 Oct; 23(39):7059-7076. PubMed ID: 29093615
[TBL] [Abstract][Full Text] [Related]
10. The use of pancreatic enzyme replacement therapy in patients with a diagnosis of chronic pancreatitis and pancreatic cancer in the US is infrequent and inconsistent.
Forsmark CE; Tang G; Xu H; Tuft M; Hughes SJ; Yadav D
Aliment Pharmacol Ther; 2020 May; 51(10):958-967. PubMed ID: 32249970
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic enzyme replacement therapy following surgery for pancreatic cancer: An exploration of patient self-management.
Dunleavy L; Al-Mukhtar A; Halliday V
Clin Nutr ESPEN; 2018 Aug; 26():97-103. PubMed ID: 29908691
[TBL] [Abstract][Full Text] [Related]
12. Contribution of pancreatic enzyme replacement therapy to survival and quality of life in patients with pancreatic exocrine insufficiency.
Layer P; Kashirskaya N; Gubergrits N
World J Gastroenterol; 2019 May; 25(20):2430-2441. PubMed ID: 31171887
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic enzyme replacement therapy in subjects with exocrine pancreatic insufficiency and diabetes mellitus: a real-life, case-control study.
Alexandre-Heymann L; Yaker F; Lassen PB; Dubois-Laforgue D; Larger E
Diabetol Metab Syndr; 2024 Feb; 16(1):39. PubMed ID: 38331895
[TBL] [Abstract][Full Text] [Related]
14. Safety and tolerability of a new formulation of pancrelipase delayed-release capsules (CREON) in children under seven years of age with exocrine pancreatic insufficiency due to cystic fibrosis: an open-label, multicentre, single-treatment-arm study.
Graff GR; McNamara J; Royall J; Caras S; Forssmann K
Clin Drug Investig; 2010; 30(6):351-64. PubMed ID: 20441244
[TBL] [Abstract][Full Text] [Related]
15. Real-World Patient Experience With Pancreatic Enzyme Replacement Therapy in the Treatment of Exocrine Pancreatic Insufficiency.
Barkin JA; Harb D; Kort J; Barkin JS
Pancreas; 2024 Jan; 53(1):e16-e21. PubMed ID: 38039440
[TBL] [Abstract][Full Text] [Related]
16. Prescription patterns of pancreatic enzyme replacement therapy for patients with pancreatic cancer in the United States.
Jain T; Sharma P; Giri B; Iyer S; Sethi V; Bava EP; Vaish U; Sahay P; Datta J; Reddy S; Bart Rose J; Khan A; Merchant N; Chari ST; Dudeja V
HPB (Oxford); 2022 Oct; 24(10):1729-1737. PubMed ID: 35717430
[TBL] [Abstract][Full Text] [Related]
17. Impact of the treatment of pancreatic exocrine insufficiency on survival of patients with unresectable pancreatic cancer: a retrospective analysis.
Domínguez-Muñoz JE; Nieto-Garcia L; López-Díaz J; Lariño-Noia J; Abdulkader I; Iglesias-Garcia J
BMC Cancer; 2018 May; 18(1):534. PubMed ID: 29728096
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic Enzyme Replacement Therapy in Patients with Non-pancreatic Digestive Conditions: A Nationwide Claims Analysis.
Phillips AE; Tang G; Wang X; Forsmark CE; Yadav D
Dig Dis Sci; 2023 May; 68(5):1754-1761. PubMed ID: 36370243
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of pancreatic enzyme replacement therapy in chronic pancreatitis: systematic review and meta-analysis.
de la Iglesia-García D; Huang W; Szatmary P; Baston-Rey I; Gonzalez-Lopez J; Prada-Ramallal G; Mukherjee R; Nunes QM; Domínguez-Muñoz JE; Sutton R;
Gut; 2017 Aug; 66(8):1354-1355. PubMed ID: 27941156
[TBL] [Abstract][Full Text] [Related]
20. CREON (Pancrelipase Delayed-Release Capsules) for the treatment of exocrine pancreatic insufficiency.
Kuhn RJ; Gelrud A; Munck A; Caras S
Adv Ther; 2010 Dec; 27(12):895-916. PubMed ID: 21086085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
